NIH Guide: Weekly Index for March 19, 2021

Funding Opportunities

• Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed)
  (PA-21-194)
  National Institute of Mental Health
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 12, 2021.
• Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Required)
  (PA-21-195)
  National Institute of Mental Health
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 12, 2021.
• Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)
  (PAR-21-061)
  National Cancer Institute
  Application Receipt Date(s): June 15, 2021; November 17, 2021; June 14, 2022; November 17, 2022; June 14, 2023; November 17, 2023
• The NCI Transition Career Development Award (K22 - Independent Clinical Trial Required)
  (PAR-21-111)
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply.
• The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed)
  (PAR-21-128)
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply.
• Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
  (PAR-21-167)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Multiple dates, see announcement.
• Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
  (PAR-21-169)
  National Institute of General Medical Sciences
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Multiple dates, see announcement.
• Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Independent Basic Experimental Studies with Humans Required)
  (PAR-21-170)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Clinical Trial Required)
  (PAR-21-171)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Clinical Trial Not Allowed)
  (PAR-21-172)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)
  (PAR-21-173)
  National Institute of General Medical Sciences
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Multiple dates, see announcement.
• Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01 Clinical Trial Optional)
  (PAR-21-175)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21 Clinical Trial Optional)
  (PAR-21-176)
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Research on Bat Immunology (R21 Clinical Trial Not Allowed)
  (PAR-21-184)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• Medical Scientist Training Program (T32)
  (PAR-21-189)
  National Institute of General Medical Sciences
  Application Receipt Date(s): Standard dates apply. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). The first application due date for this FOA is May 25, 2021. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required)
  (PAR-21-318)
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply.
• High-Priority Behavioral and Social Research Networks in Alzheimers Disease and Alzheimers Disease-Related Dementias (R24 Clinical Trial Optional)
  (RFA-AG-22-012)
  National Institute on Aging
  Application Receipt Date(s): June 23, 2021
• High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Optional)
  (RFA-AG-22-013)
  National Institute on Aging
  Application Receipt Date(s): June 23, 2021
• Early-Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U01 Clinical Trial Not Allowed)
  (RFA-AI-21-020)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• Enhancement or Sustainment of Data Science Tools for Infectious and Immune-Mediated diseases (U24 Clinical Trial Not Allowed)
  (RFA-AI-21-021)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• Exploratory Data Science Methods and Algorithm Development in Infectious and Immune-mediated Diseases (R21 Clinical Trial Not Allowed)
  (RFA-AI-21-035)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• Core Centers for Clinical Research (CCCR) (P30)- Clinical Trial Not Allowed
  (RFA-AR-22-002)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): September 13, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. No late applications will be accepted for this Funding Opportunity Announcement.
• Program to Advance the Career Development of Scientists from Diverse Backgrounds Conducting Nutrition, Obesity, Diabetes, and Related Research (U24 Clinical Trial Optional)
  (RFA-DK-20-034)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Office of Disease Prevention
  Application Receipt Date(s): June 17, 2021
• The Autoantigens and Neoantigens Function in the Etiology and Pathophysiology of Type 1 Diabetes (R01 Clinical Trial Optional)
  (RFA-DK-21-004)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Multiple dates, see announcement.
• SmartTots (Strategies for Mitigating Anesthesia-Related neuroToxicity in Tots) Public-Private Partnership (PPP) under PASI (Pediatric Anesthesia Safety Initiative) (U01) Clinical Trials Not Allowed
  (RFA-FD-21-025)
  Food and Drug Administration
  Application Receipt Date(s): May 24, 2021, by 11:59 PM Eastern Time.
• Analgesic, Anesthetic and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) (U01) Clinical Trials Not Allowed
  (RFA-FD-21-026)
  Food and Drug Administration
  Application Receipt Date(s): May 24, 2021, by 11:59 PM Eastern Time.
• Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 - Independent Clinical Trial Not Allowed)
  (RFA-OD-21-005)
  Office of Behavioral and Social Sciences Research
  National Institute on Alcohol Abuse and Alcoholism
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Center for Complementary and Integrative Health
  Office of Research on Women's Health
  Office of Disease Prevention
  Application Receipt Date(s): June 4, 2021